Abstract
This chapter deals with the effects of gonadal steroids and their synthetic equivalents, glucocorticoids, and several anterior hypophysical hormones. It also describes the effects of oral hyglycemic and antithyroid drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adlercreutz H, Tenhunen R (1970) Some aspects of the interaction between natural and synthetic female sex hormones and the liver. Am J Med 49:630
Agrawal BL, Zelkowitz L (1981) Bone “flare”, hypercalcemia and jaundice after tamoxifen therapy. Arch Intern Med 141:1240
Alpers DH, Isselbacher KJ (1975) Fatty liver: biochemical and clinical aspects. In: Schiff L (ed) Diseases of the liver, 4th edn. Lippincott, Philadelphia, pp 815–832
Alpert LI (1976) Veno-occlusive disease of the liver associated with oral contraceptives: case report and review of the literature. Hum Pathol 7:709
Ameriks JA, Thompson NW, Frey CF, Appelman HD, Walter JF (1975) Hepatic cell adenomas, spontaneous liver rupture, and oral contraceptives. Arch Surg 110:548
Amtrup F, Slottved J, Svanholm H (1980) Liver cell carcinoma in young women possibly induced by oral contraceptives. Acta Obstet Gynecol Scand 59:567
Anthony AP (1975) Hepatoma associated with androgenic steroids. Lancet 1:685
Antopol W (1950) Anatomic changes in mice treated with excessive doses of cortisone. Proc Soc Exp Bioi Med 73:262
Arias IM (1963) Effects of a plant acid (icterogenin) and certain anabolic steroids on the hepatic metabolism of bilirubin and sulfobromophthalein (BSP). Ann NY Acad Sci 104:1014
Arosio M, Bazzoni N, Ambrosi B, Faglia G (1988) Acute hepatitis after treatment of acromegaly with octreotide. Lancet II:1498
Bannister P, Sheridan P, Losowsky MS (1985) Identification and characterization of the human hepatic androgen receptor. Clin Endocrinol (Oxf) 23:495
Bennion LJ, Ginsberg RL, Garnick MH, Bennett PH (1976) Effects of oral contraceptives on the gallbladder bile of normal women. N Engl J Med 244:189
Bis KA, Waxman N (1976) Rupture of the liver associated with pregnancy: a review of the literature and report of two cases. Surg Gynecol Obstet 31:763
Bissell DM, Schmidt R (1987) Hepatic porphyrias. In: Schiff L, Schiff ER (eds) Diseases of the liver, 6th edn. Lippincott, Philadelphia
Blackburn AM, Amiel SA, Millis RR et al. (1984) Tamoxifen and liver damage. Br Med J 289:288
Bloodworth JMB Jr (1963) Morphologic changes associated with sulfonylurea therapy. Metabolism 12:287
Bottger G, Schiebold KO, Ulmann B, Rockel A (1981) Liver rupture after several years of hormone contraception. Z Gesamte Inn Med 36:226
Boue F, Caffin B, Oelfraisay J-F (1986) Danazol and cholestatic hepatitis (letter). Ann Intern Med 105:139
Boyer JL (1978) Androgenic-anabolic steroid associated peliosis hepatis in man - a review of 38 reported cases. Adv Pharmacol Ther 8:175
Brooks JJ (1982) Hepatoma associated with diethylstilbestrol therapy for prostatic carcinoma. J Urol 128:1044
Brosens I, Johannisson E, Baulieu E-E et al. (1986) Oral contraceptives and hepatocellular carcinoma. Br Med J 292:1667
Buamah PK (1985) An apparent danazol-induced primary hepatocellular carcinoma. J Surg Oncol 28:114
Burger RA, Marcuse PM (1952) Peliosis hepatis. Report of a case. Am J Clin Pathol 22:569
Carrasco D, Barrachina M, Prieto M, Berenguer J (1984) Clomiphene citrate and livercell adenoma. N Engl J Med 310:1120
Carrasco D, Prieto M, Pallardo L et al. (1985) Multiple hepatic adenomas after longterm therapy with testosterone enanetrate. J Hepatol 1:573
Christensen SE, Andersen VR, Vilstrup H (1981) A case of hepatoma in pregnancy associated with earlier oral contraception. A case report. Acta Obstet Gynecol Scand 60:519
Christopherson WM, Mays ET (1979) Relation of steroids to liver oncogenesis. J Toxicol Environ Health 5:207
Clarke BF, Campbell IW, Ewing DJ et al. (1974) Generalized hypersensitivity reaction and visceral arteritis with fatal outcome during glibenc1amide therapy. Diabetes 23:739
Coe JE, Ishak KG, Ross MJ (1983) Diethylstilbestrol-induced jaundice in the Chinese and Armenian Hamster. Hepatology 3:489
Creuzfeldt W (1975) Oral antibiabetika. In: Gerok W, Sickinger K (eds) Drugs and the liver Schattauer, Stuttgart, pp 366–373
Dahl P, Schmid E (1969) Arzneimittelikterus durch Ostrogene beim Mann. Z Gastroenterol 7:183
Dalen E, Westerholm B (1974) Occurrence of hepatic impairment in women jaundiced by oral contraceptives and their mothers and sisters. Acta Med Scand 195:459
Dean PJ, Haggitt RC, O’Hara CJ (1985) Malignant epithelioid hemangioepithelioma of the liver in young women. Relationship to oral contraceptive use. Am J Surg Pathol 9:695
De Pagter AG, van Berge Henegouwen GP, Brandt KH, Bronkhorst FB (1979) Orale anticonceptiva en de lever. Ned Tydochr Geneeskd 123:881
Despopoulus AA (1971) Hepatic and renal excretory metabolism of bile salts: a backgroud for understanding steroid-induced cholestasis. J Pharmacol Exp Ther 176:273
Edmondson HA, Henderson B, Benton B (1976) Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 294:470
Edmondson HA, Reynolds TB, Henderson B, Benten B (1977) Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med 86:180
Edwards AM, Eliott WH (1975) Induction of 8-aminolevulinic acid synthetase in isolated rat liver cells by steroids. J Bioi Chern 250:2750
Eisalo A, Jarvinen P A, Luukkainen T (1964) Hepatic impairment during the intake of contraceptive pills. Clinical trial with postmenopaual women. Br Med J 2:426
Elias E, Igbal S, Knutton S et al. (1983) Increased tight junction permeability: a possible mechanism of estrogen cholestasis. Eur J Clin Invest 13:383
Elias E, Igbal S, Knutton S et al. (1983) Increased tight junction permeability: a possible mechanism of estrogen cholestasis. Eur J Clin Invest 13:383
Elias H, Schwinner D (1945) The hepatotoxic action of diethylstilbesterol with report of a case. Am J Med Sci 209:602
Ellis EF (1978) Oral contraceptives: cholangiocarcinoma-death. Clin Alert 54
Falk H, Thomas LB, Popper H (1979) Hepatic angiosarcoma associated with androgenic-anabolic steroids. Lancet II: 1120
Fedotin MS, Lefer LG (1975) Liver disease caused by propylthiouracil. Arch Intern Med 135:319
Fermand JP, Levy Y, Bauscary D et al. (1990) Danazol-induced hepatocellular adenoma. Am J Med 88:5291
Fitz JG (1984) Oral contraceptives and benign tumors of the liver. West J Med 140: 260
Forman D, Vincent TJ, Doll R (1986) Cancer of the liver and the use of oral contraceptives. Br Med J 292:1357
Foss G L, Simpson SL (1959) Oral methyltestosterone and jaundice. Br Med J 1:259
Frederick WC, Howard RG, Spatola S (1974) Spontaneous rupture of the liver in patients using contraceptive pills. Arch Surg 108:93
Freedman AN (1982) Liver lesions and oral contraceptives. Can Med Assoc J 126: 1149
Gallagher TF Jr, Mueller MN, Kappas A (1966) Estrogen pharmacology. IV. Studies on the structural basis for estrogen-induced impairment of liver function. Medicine 45:471
Garrigues-Gil V, Berenguer-Lapuerta JB, Ponce-Garcia J et al. (1986) A non-e17 alkylated steroid and long-term cholestasis. Ann Intern Med 104: 135
Gibson T, Graham R (1983) Cyclofenil treatments of scleroderma. A controlled study. Br J Rheum 22:218
Gilbert EF, DaSilvia A-Q, Queen DM (1963) Intrahepatic cholestasis with fatal termination following norethandrolone therapy. JAMA 185:538
Glober GA, Wilkerson JA (1968) Biliary cirrhosis following the administration of methyltestosterone. JAMA 204:170
Goldfarb S (1976) Sex hormones and hepatic neoplasia. Cancer Res 36:2584
Goldstein MJ, Rothenberg AJ (1966) Jaundice in a patient receiving acetohexamide. N Engl J Med 275:97
Goodman R, Dean PJ, Radparvar A et al. (1987) Glyburide-induced hepatitis. Ann Intern Med 106:837
Gregory DH, Zaki GF, Sarosi GA, Carey JB Jr (1967) Chronic cholestasis following prolonged tolbutamide administration. Arch Pathol 84: 194
Haemmarli UP, Wyss HI (1967) Recurrent intrahepatic cholestasis of pregnancy. Medicine 46:299
Ham JM, Fracs F, Pirola RC et al. (1980) Hemangioendothelial sarcoma of the liver associated with long-term estrogen therapy in a man. Dig Dis Sci 25: 879
Hartley RA, Boitnott JK, Ibeer FL (1969) Topics in clinical medicine: the liver and oral contraceptives. Johns Hopkins Med J 124:112
Hayashida CY, Duarte AJ, Sato AE, Yomoslura-Kaesboro EH (1991) Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil. J Endocrinol Invest 13:937
Heaney RP, Whedon GD (1958) Impairment of hepatic bromosulphalein clearance by two 17-substituted testosterones. J Lab Clin Med 52:169
Helling TS, Wood WG (1982) Oral contraceptives and cancer of the liver: a review with two additional cases. Am J Med 77:504
Henderson BE, Preston-Martin S, Edmondson HA et al. (1983) Hepatocellular carcinoma and oral contraceptives. Br J Cancer 44:437
Hibbard LT (1976) Spontaneous rupture of the liver in pregnancy: a report of eight cases. Am J Obstet Gynecol 126:334
Hill RB Jr (1961) Fatal fat embolism from steroid-induced fatty liver. N Engl J Med 165:318
Hoch-Ligeti C (1978) Angiosarcoma of the liver associated with diethylstilbestrol. JAMA 240:1510
Ingelmo M, Vivanias J, Brugero M et al. (1980) Angitis por hypersensibiladad hepatitis granuloma to sa indicuda a por glibenclamide: a propositon de un casro. Med Clin 75:306
In: Rentchnick P, Horfarth C, Senn HJ (eds) Recent results in cancer research, vol 66. Springer, Berlin Heidelberg New York, p 73
Ishak KG (1988) Benign tumors and pseudotumors of the liver. Appl Pathol 6:82
Ishak KG, Rabin L (1975) Benign tumors of the liver. Med Clin North Am 59: 995
Ishak KG, Zimmerman HJ (1987) Hepatotoxic effects of the anabolic/androgenic steroids. Semin Liver Dis 7:230
Iverson D-E, Thoresen SO (1986) Oral contraceptives and hepatocellular carcinoma. Br Med J 292:1668
Jacobs MB (1984) Hepatic infarction related to oral contraceptive use. Arch Intern Med 144:642
Jones JP, Engleman EP, Najarian JS (1965) Systemic fat embolism after renal homotransplantation and treatment with corticosteroids. N Engl J Med 273: 1453
Kang H, Cho JD, Jung IG et al. (1990) A case of methimazole-induced acute hepatic failure in a patient with chronic hepatitis B carrier. Korean J Intern Med 5:69
Kappas S, Granick S (1968) Experimental hepatic porphyria: studies with steroids of physiological origin in man. Ann NY Acad Sci 151:842
Karasawa T, Shikata T, Smith RD (1979) Peliosis hepatis. Report of nine cases. Acta Pathol Jpn 29:457
Keeffe EB, Blankenship NM, Scharschmidt BF (1980) Alteration of rat liver plasma membrane fluidity and ATPase activity by chlorpromazine hydrochloride and its metabolites. Gastroenterology 79:222
Keifer WS, Scott JC (1977) Liver neoplasms and the oral contraceptives. J Obstet Gynecol 128:448
Kerlin P, Davis GL, McGill DB et al. (1983) Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology 84:994
Kirtley WR (1957) Occurrence of sensitivity and side reactions following carbutamide. Diabetes 6:72
Klaassen CD, Watkins JB (1984) Mechanisms of bile formation, hepatic uptake and biliary excretion. Pharmacol Rev 36:1
Klatskin G (1977) Hepatic tumors. Possible relationship to use of oral contraceptives. Gastroenterology 73:386
Kobayashi M, Higashiyama S, Nagakiri S et al. (1981) A case of drug-induced liver injury with positive LE phenomenon caused by meraczole. Acta Hematol Jpn 22:1453
Kohigashi K, Fukuda Y, Imura H, Nakano H (1986) Promotive effect of estrogen on hepatocarcinogenesis and estrogen receptor in male rats. Acta Hepatol Jpn 27:220
Konturri M, Sotaniemi E, Ahlgvist J (1972) Liver damage and estrogen therapy of prostatic cancer. Scand J Urol Nephrol 6:289
Kory RC, Bradley MH, Watson RN et al. (1959) Six month evaluation of anabolic drug. norethandrolone in underweight persons. II. Bromsulfalein (BSP) retention and liver function. Am J Med 26:243
Kositchek RJ, Cullen RA (1970) Hemangiomatosis of the liver with thrombosis following use of an oral contraceptive. Calif Med 113:70
Koszalka MF (1957) Medical obstructive jaundice: report of a death due to methylestosterone. Lancet 77:51
Kreek MJ (1987) Female sex steroids and cholestasis. Semin Liver Dis 7:8
Langlands AD, Martin WM (1975) Jaundice associated with norethisteronc-acetate treatment of breast cancer. Lancet 1:584
Leevy CM, Cherrick GR, Davidson CS (1961) Observations of norethandroloneinduced abnormalities in plasma decay of sulfobromophthalein and indocyanine green. J Lab Clin Med 57:918
Leissner KH, Wedel H, Scherstein T (1977) Comparison between the use of oral contraceptives and the incidence of surgically confirmed gallstonc disease. Scand J Gastroenterol 12:893
Lewis JH, Tice HL, Zimmerman HJ (1983) Budd-Chiari syndrome associated with oral contraceptive steroids. Review of treatment of 47 cases. Dig Dis Sci 28:673
Liaw YF, Huang MJ, Fan KD et al. (1993) Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Ann Intcrn Med 118:424
Lieberman DA, Keeffe EB, Stenzel P (1984) Severe and prolonged oral contraceptive jaundice. J Clin Gastroenterol 6:145
Lipstate LK, Stromeyer FW, Welsh RA (1981) Benign hepatocellular tumors: a regional survey. South Med J 74:397
Littlewood ER, Barrison IG, Murray-Lyon IM, Paradinas FJ (1980) Cholangiocarcinoma and oral contraceptives. Lancet 11:310
Loomus GN, Ameja P, Bota RA (1983) A case of peliosis hepatis in association with tamoxifen therapy. Am J Clin Pat hoi 80:881
Lowdell CP, Murray-Lyon IM (1985) Reversal of liver damage due to long term methyltestosterone and safety of non-17 a-alkylated androgens. Br Med J 291:637
Mach B, Field RA, Taft E (1959) Metahexamide jaundice. Report of a case. N Engl J Med 261:438
Machin DG, Crosbie RB (1986) Hepatic mesenchymoma in an adult. Br Med J 292:450
Maddrey WC (1987) Hepatic vein thrombosis (Budd-Chiari syndrome): possible association with the use of oral contraceptives. Semin Liver Dis 7:32
Maggiori G, Larizza D, Lorini R et al. (1989) Propylthiouracil hepatotoxicity mimicking autoimmune chronic active hepatitis in a girl (letter). J Pediatr Gastroenterol Nutr 8:547
Martinez-Manautou J, Aznar-Ramos R, Bautista-O’Farril J. Gonzales-Angulo A (1970) The ultrastructure of liver cells in women under steroid therapy. II. Contraceptive therapy. Acta Endocrinol (Copenh) 65:207
McGaughan GW, Bilous MJ, Gallagher ND (1985) Long-term survival with tumor regression in androgen-induced liver tumors. Cancer 56:2622
Meijers WH, Willemse PHB, Sleijfer D, Mulder NH, Grond J (1986) Hepatocellular damage by cyproterone acetate. Eur J Cancer Clin Oncol 22: 1121
Melamed I, Bujanover Y, Hammer J, Spirer Z (1982) Hepatoblastoma in an infant born to a mother after hormonal treatment for sterility. N Engl .J Med 307:820
Metreau JM, Dhumeaux D, Berthelot P (1972) Oral contraceptives and the liver. Digestion 7:318
Mettlin C, Nachimuthu N (1981) Studies on the role of oral contraceptive use in the etiology of benign and malignant liver tumors. J Surg Oncol 18:73
Middleton C McCaughan GW, Painter DM et al. (1989) Danazol and hepatic neoplasia. A case report. Aust NZJ Med 19:733
Minocha A, Dean HA Jr (1991) Octreotide-induced acute hepatic toxicity (letter). Am J Gastroenterol 86:515
Molleken K (1979) Leberbiosiebefunde nach Einnahme oraler Kontrazeptiva. Zentralbl Allg Pathol Anat 123:195
Monckaton-Capeman PW, Cripps J, Summerly R (1966) Cutaneous hepatic porphyria and oestrogens. Br Med J 1:461
Monroe PS, Riddell RH, Siegler M et al. (1981) Hepatic angiosarcoma: possible relationship to long-term oral contraceptive ingestion. JAMA 246:64
Mosonyi L (1956) Multiple benign hepatomas and virilisation by ovarian tumor. Lancet 11:23
Mueller MN, Kappas A (1964) Estrogen pharmacology. I. The influence of estradiol and estriol on hepatic disposal of sulfobromophthalein. J Clin Invest 43:1905
Nadell J, Kosek J (1977) Peliosis hepatis: twelve cases associated with oral androgen therapy. Arch Pathol Lab Med 101:405
Nagasue N, Ito A, Yukaya H, Ogaw Y (1985) Androgen receptors in hepatocellular carcinoma and surrounding parenchyma. Gastroenterology 89:643
Nakajima T, Mizushima N, Matsuda M et al. (1986) Fulminant hepatic failure associated with aplastic anemia after treatment with danazol. Br J Obstet Gynacol 93:1013
Nakao NL, Gelb AM, Stenger R, Sitgel JH (1985) A case of chronic liver disease due to tolazamide. Gastroenterology 89:192
Namahisa T, Yamagudi K, Kitami N (1975) Der Lymphozyten Transformationstest bei allergischen Arzeneimittelshaden de Leber. Leber Magen Darm 5:73
Nand S, Gordon LI, Brestan E et al. (1982) Benign hepatic cyst in a patient on antiestrogen therapy for metastatic breast cancer. Cancer 50:1882
Nesher G, Dolberg L, Zimran A, Hershko A (1985) Hepatosplenic peliosis after danazol and glucocorticoids for ITP. Lancet 1:242
Neuberger J, Forman D, Doll R, Williams R (1986) Oral contraceptives and hepatocellular carcinoma. Br Med J 292:1355
Nordsten M (1985) Hemangiosarcoma hepatis asocieret med brug of androgene steroider. Ugeskr Laeger 147:2615
O’Sullivan JP, Rosswick RP (1976) Oral contraceptives and malignant hepatic tumors. Lancet 1:1124
Ohsawa T, Iwaskito S (1986) Hepatitis associated with danazol (letter). Drug Intell Clin Pharmacol 20:889
Olsson R, Tyllstrom J, Zettergren L (1983) Hepatic reactions to cycIofenil. Gut 24:260
Orellana-Alcade JM, Deminquez JP (1966) Jaundice and oral contraceptive drugs. Lancet 11:1278
Orlandi F, Jezequel AM (1966) Pathogenesis of the cholestasis induced by C-17 alkylated steroids: ultrastructural and functional changes of the liver cells during treatment. Rev Int Hepat 16:331
Paumgartner G, Reichen J, Von Bergmann K, Preisig R (1976) Elaboration of hepatocytic bile. Bull NY Acad Med 51:455
Pecking A, Lelloy JM, Najean Y (1980) Hepato-toxicite des androgenes au cour du traitment des aplasies medullaires. Nouv Rev Fr Hematol 22:257
Pelletier G, Frija J, Szekely A-M et al. (1984) L’adenome du foie chez l’homme. Gastroenterol Clin Biol 8:269
Perez V, Gorodisch S, DeMartire J et al. (1969) Oral contraceptives: long-term use produces fine structural changes in liver mitochondria. Science 165:805
Perez-Mera RA, Shields CE (1962) Jaundice associated with norethindrone acetate therapy. N Engl J Med 267:1137
Peterson IM, Neumann CH (1984) Focal hepatic infarction with bile lake formation. Am J Roentgenol 142:1155
Phillips M, Oda M, Funatsu K (1978) Evidence for microfilament involvement in norethandrolone-induced intrahepatic cholestasis. Am J Pathol 93:729
Phillips MJ, Poucell S, Oda M (1986) Biology of disease: mechanisms of cholestasis. Lab Invest 54:593
Pitot HC (1988) Hepatic neoplasia: chemical induction. In: Arias IM, Jacoby WB, (eds) The liver. Biology and pathobiology. Raven, New York, pp 1125–1146 (letter) (JAMA 253:1457,1985)
Plaa GL, Priestly BG (1977) Intrahepatic cholestasis induced by drugs and chemicals. Pharmacol Rev 28:207
Porter JB, Jick H, Ylvisaker JT (1981) Malignant liver tumor associated with oral contraceptive use. Pharmacotherapy 1:160
Porter LE, van Thiel DH, Eagon PK (1987) Estrogens and progestins as tumor inducers. Semin Liver Dis 7:24
Poulsen H, Winkler K (1973) Liver disease with periportal sinusoidal dilatation. Digestion 8:441
Rank JM, Olson RC (1989) Reversible cholestatic jaundice caused by acetohexamide. Gastroenterology 96:1607
Reichen J, Simon FRL (1984) Mechanisms of cholestasis. Int Rev Exp Pat hoi 26: 231
Reyes H (1982) The enigma of intrahepatic jaundice of pregnancy. Lessons from Chile. Hepatology 2:86
Reyes H, Ritalta J, Gonzales-Ceron M (1976) Intrahepatic jaundice of pregnancy in a large kindred. Gut 17:709
Reynolds TB (1987) Budd-Chiari syndromes. In: Schiff L, Schiff ER (eds) Diseases of the liver, 6th edn. Lippincott, Philadelphia, pp 1466–1472
Rifkind AB, Gilette PN, Song CS, Kappas A (1970) Induction of hepatic 8-aminolevulinic acid synthetase by oral contraceptive steroids. J Clin Endocrin Metab 30:330
Riipa P, Kauppil A, Sundstrom H et al. (1984) Hepatic impairment during simultaneous administration of medroxyprogesterone acetate and tamoxifen in the treatment of endometrial and ovarian carcinoma. Anticancer Res 4:109
Roman P, Hecker R (1968) The liver toxicity of oral contraceptives, a critical review of the literature. Med J Aust 2:682
Rooks JB, Dry HW, Ishak KG et al. (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242:644
Rosinus Y, Maurer R (1981) Diathylstilbestrol-induziertes Leberzell Karzinom. Schweiz Med W ochenschr 111:1139
Rossi G, Gabbi E, Serra L (1992) Acute hepatitis induced by cyclofenil: a case report. Ital J Gastroenterol 24:77
Routier G, Corette L, Dannas P (1967) Hepatite severe et progestatifs de synthese. J Sci Med Lillte 85:229
Rowley PT, Kurnick J, Cheville R (1970) Hereditary haemorrhagic telangiectasia: aggravation by oral contraceptives. Lancet 1:474
Schaffner F (1966) The effect of oral contraceptives on the liver. JAMA 198:1019
Schaffner F, Raisfeld IH (1969) Drugs and the liver. A review of metabolism and adverse reactions. Adv Intern Med 15:221
Schaffner F, Popper H, Chesrow E (1959) Cholestasis produced by the administration of norethandrolone. Am J Med 26:249
Schaffner F, Popper H, Perez Y (1960) Changes in bile canaliculi produced by norethandrolone: electron microscopic study of human and rat liver. J Lab Clin Med 56:623
Schneider HL, Hornbach KD, Kniaz JL, Efrusy ME (1984) Chlorpropamide hepatotoxicity: report of a case and review of the literature. Am J Gastroenterol 79:721
Schonberg LA (1982) Peliosis hepatis and oral contraceptives. Reprod Med 27: 763
Schreiber AH, Simon FR (1983) Estrogen-induced cholestasis: clues to pathogenesis and treatment. Hepatology 3:607
Seki K, Minami Y, Nishikawa M et al. (1983) Non-alcoholic steatohepatitis induced by massive dose estrogen therapy. Gastroenterol Jpn 18:197
Silva MO, Reddy KR, McDonald T et al. (1989) Danazol-induced cholestasis. Am J Gastroenterol 84:426
Smetana H (1963) The histopathology of drug-induced liver disease. Ann NY Acad Sci 104:821
Song CS, Kappas A (1975) Hormones and hepatic function. In: Schiff L (ed) Diseases of the liver, 4th edn. Lippincott, Philadelphia, pp 163–183
Sotaniemi E, Kreus KE, Scheinin T (1964) Oral contraceptives and liver damage. Br Med J 2:1264
Sontaniemi EA, Alvaikko MJ, Kaipainen WJ (1975) Primary liver cancer associated with long-term oestrogen therapy. Ann Clin Res 7:287
Stricker BHC (1992) Drug induced hepatic injury, 2nd edn. Elsevier, Amsterdam
Stubblefield PG (1984) Oral contraceptives and neoplasia. J Reprod Med 29:524
Sturvetant FM (1979) Oral contraceptives and liver tumors. In: Moghissi KS (ed) Controversies in contraception. Williams and Wilkins, Baltimore, pp 93–150
Tanaka K, Kean EA, Johnson B (1976) Jamaican vomiting sickness: biochemical investigation of two cases. N Engl J Med 295:461
Taniya T, Noguchi M, Taiiri K et al. (1987) A case report of hyperlipenia with giant fatty liver during adjuvant therapy by tamoxifen. Gan No Rinsho 33:300
Tanyol H, Rehfuss ME (1955) Hepatotoxic effect of cortisone in experimental animals. Am J Dig Dis 22:169
Taylor W, Snowball S (1984) The effects of long-term administration of methyltestosterone on the development of liver lesions in BALB/c mice. J Pathol 143:211
Terblanche J, Goldin AR, Campbell JAH et al. (1978) Liver tumors associated with the use of contraceptive pills. S Afr Med J 53:439
Ticktin HE, Zimmerman HJ (1966) Effects of synthetic anabolic agent on hepatic function. Am J Med Sci 251:674
Tuchweber B, Weber A, Roy CC, Yousef IM (1986) Mechanisms of experimentally induced intrahepatic cholestasis. Prog Liver Dis 8:161
Turani H, Levi J, Zevin D et al. (1983) Hepatic lesions in patients on anabolic androgenic therapy. Isr J Med Sci 19:332
Valla D, Casadevall N, Lacombe C et al. (1985) Primary myeloproliferative disorder and hepatic vein thrombosis. Ann Intern Med 103:329
Valla D, Le MG, Poynard T et al. (1986) Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case control study. Gastroenterology 90:807
Van Thiel DH, de Belle R, Mellow M et al. (1974) Tolazamide hepatotoxicity. A case report. Gastroenterology 67:506
Vincens M, Athen N, Daugacies N et al. (1984) Augmentation des transaminases lor de trailment pae Ie clanazol ches des maleates Ii pagues. Therapie 39:541
Weill BJ, Menkes CJ, Cormier C et al. (1988) Hepatocellular carcinoma after danazol therapy. J Rheumato l15:1447
Weinstein A, Massie R, Scoville AB (1963) The use of azepinamide in the management of diabetes mellitus, with a report of jaundice as a complication, and comments relative to the use of oral hypoglycemic agents. Am J Med Sci 245:432
Werner SC (1947) Clinical syndromes associated with gonadal failure in man. Am J Med 3:52
Werner SP, Hanger FM, Kritzler RA (1950) Jaundice during methyltestosterone therapy. Am J Med 8:325
Westaby D, Williams R (1981) Androgen and anabolic steroid-related tumors. In: Davis M, Trediger JM, Williams R (eds) Drug reactions and the liver. Pitman, Bath pp 284–289
Wilder EM (1962) Death due to liver failure following the use of mephandrosterone. Can Med Assoc 1 87:768
Wilson JHP (1982) Oral contraceptives and hepatic tumors. Agressologie 23:21
Wongpactoon V, Russell RF, Mills PR,Patrick RS (1981) Intrahepatic cholestasis and cutaneous bullae associated with glibenclamide therapy. Postgrad Med 1 57:244
Wynn V (1977) Metabolic effects of danazol. J Int Med Res 5:25
Zafrani ES, Pinadeau Y, Dhumeaux D (I983) Drug-induced vascular lesions of the liver. Arch Intern Med 143:495
Zimmerman HJ (1963) Clinical and laboratory manifestations of hepatotoxicity. Ann NY Acad Sci 104:954
Zimmerman HJ (1978) Hepatotoxicity adverse effects of drugs and other chemicals in the liver. Appleton Century Croft, New York
Zimmerman HJ, Lewis JH (1987) Drug-induced cholestasis. Med Toxicol 2: 112 .
Zimmerman HJ, Maddrey WC (1987) Toxic and drug-induced hepatitis. In: Schiff L, Schiff ER (eds) Diseases of the liver. 6th edn. Lippincott. Philadelphia. pp 591–667
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zimmerman, H.I., Ishak, K.G. (1996). Steroids and Other Hormones. In: Cameron, R.G., Feuer, G., de la Iglesia, F.A. (eds) Drug-Induced Hepatotoxicity. Handbook of Experimental Pharmacology, vol 121. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61013-4_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-61013-4_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64657-7
Online ISBN: 978-3-642-61013-4
eBook Packages: Springer Book Archive